NAAA
DGX icon

New Age Alpha Advisors’s Quest Diagnostics DGX Stock Holding History

New Age Alpha Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9K Buy
127
+3
+2% +$589 ﹤0.01% 906
2026
Q1 		$24.3K Buy
124
+23
+23% +$4.47K ﹤0.01% 745
2025
Q4 		$17.5K Buy
+101
New +$18.4K ﹤0.01% 749

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

New Age Alpha Advisors's DGX Position: Q2 2026 in Review

New Age Alpha Advisors increased its Quest Diagnostics (DGX) stake by 2.4% in Q2 2026, buying an estimated $589 and bringing the position to 127 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #906.

New Age Alpha Advisors first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • New Age Alpha Advisors held 127 shares of Quest Diagnostics worth $26.9K as of Q2 2026.
  • New Age Alpha Advisors bought 3 Quest Diagnostics shares in Q2 2026, an estimated $589.
  • Quest Diagnostics made up ﹤0.01% of New Age Alpha Advisors's portfolio in Q2 2026, its #906 holding.
  • New Age Alpha Advisors first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.